- Home
- CCEL vs PCLA Comparison
CCEL vs PCLA Comparison
Compare CCEL & PCLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCEL
- PCLA
- Stock Information
- Founded
- CCEL 1989
- PCLA 2008
- Country
- CCEL United States
- PCLA Japan
- Employees
- CCEL N/A
- PCLA N/A
- Industry
- CCEL Managed Health Care
- PCLA Building Products
- Sector
- CCEL Health Care
- PCLA Consumer Discretionary
- Exchange
- CCEL Nasdaq
- PCLA Nasdaq
- Market Cap
- CCEL 39.9M
- PCLA 32.3M
- IPO Year
- CCEL 1997
- PCLA 2025
- Fundamental
- Price
- CCEL $4.89
- PCLA $2.48
- Analyst Decision
- CCEL Strong Buy
- PCLA
- Analyst Count
- CCEL 1
- PCLA 0
- Target Price
- CCEL $8.50
- PCLA N/A
- AVG Volume (30 Days)
- CCEL 13.3K
- PCLA 2.3M
- Earning Date
- CCEL 07-14-2025
- PCLA 01-01-0001
- Dividend Yield
- CCEL 19.76%
- PCLA N/A
- EPS Growth
- CCEL N/A
- PCLA N/A
- EPS
- CCEL 0.01
- PCLA N/A
- Revenue
- CCEL $32,102,750.00
- PCLA $5,475,228.00
- Revenue This Year
- CCEL $2.49
- PCLA N/A
- Revenue Next Year
- CCEL $0.95
- PCLA N/A
- P/E Ratio
- CCEL $560.42
- PCLA N/A
- Revenue Growth
- CCEL 2.33
- PCLA 40.19
- 52 Week Low
- CCEL $4.75
- PCLA $0.37
- 52 Week High
- CCEL $9.43
- PCLA $9.80
- Technical
- Relative Strength Index (RSI)
- CCEL 45.67
- PCLA N/A
- Support Level
- CCEL $4.87
- PCLA N/A
- Resistance Level
- CCEL $6.35
- PCLA N/A
- Average True Range (ATR)
- CCEL 0.27
- PCLA 0.00
- MACD
- CCEL -0.02
- PCLA 0.00
- Stochastic Oscillator
- CCEL 8.11
- PCLA 0.00
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.
About PCLA PicoCELA Inc. American Depositary Shares
PicoCELA Inc specializes in manufacturing, installing, and servicing enterprise wireless mesh solutions. The company generates revenue from two main sources: product equipment sales, and Software as a Service (SaaS) and maintenance services. The company develops the PCWL series of mesh Wi-Fi access points, which utilize its proprietary PicoCELA Backhaul Engine (PBE) technology to enable wireless communication. The company outsources manufacturing and sells these devices directly to customers through distributors. Additionally, the company offers a cloud portal service in a SaaS model, allowing users to monitor connectivity and traffic at their access points. This platform also supports the installation of proprietary edge-computing software into the devices.